QUASYS guides medical startups and enterprises from concept through design control, clinical validation, and regulatory approval — in every major market worldwide.
QUASYS is the most valuable and experienced Medical Device Consulting Company in Asia. For over 19 years, we have partnered with medical device companies — from emerging startups to the world's largest organizations — across the USA, Europe, and Asia Pacific.
We aren't just lifelong consultants or template developers. With decades of corporate experience, we navigate the complexities of medical device development to deliver meaningful innovation. Our team has hands-on expertise in technical, management, marketing, and regulatory requirements.
We are one of the top consultants in the world with hands-on experience dealing with Medical Devices with Software — both Software as Medical Device and Medical Devices having Software as part of them.
From the first whiteboard sketch to world-market commercialization — QUASYS covers every discipline your device needs.
Complete design control framework per FDA 21 CFR Part 820, ISO 13485, and EU MDR 2017/745. Design History File management from day one.
IEC 62304-compliant software lifecycle management. Full-stack medical device software, embedded firmware, and SaMD development.
Market access strategy and registration across 50+ countries. FDA 510(k), CE Marking, TGA, PMDA, ANVISA, and all major global markets.
Clinical Evaluation Reports (CER), PMCF planning, IDE submissions, and complete clinical evidence generation for regulatory submissions.
FDA pre/post-market cybersecurity, HIPAA compliance, GDPR Privacy by Design, IEC 81001-5-1, and threat modeling for connected devices.
Human Factors Engineering per IEC 62366-1. Formative and summative usability evaluations, use-related risk analysis, and HFE documentation.
ISO 14971:2019 risk management from hazard identification through benefit-risk justification. FMEA, FTA, and post-market vigilance.
ISO 13485:2016 QMS design and implementation. FDA QSR, MDSAP audit readiness, GMP assessments, CAPA systems, and document control.
Post-market surveillance systems, vigilance reporting, PSUR preparation, post-market clinical follow-up (PMCF), and complaint handling.
Design control decisions made at the beginning of R&D profoundly impact your market outcome. We build the right framework before development starts.
From embedded firmware to AI-powered diagnostics — QUASYS has the deep technical expertise your device demands.
QUASYS is among the world's pioneers in SaMD, with experts working in this domain since 2000. We have cleared devices across US, Europe, Asia, and Australia regulations many times.
We have successfully validated and cleared AI-powered medical devices across ophthalmology, radiology, pathology, and disease management — navigating the FDA's AI/ML SaMD action plan and EU MDR requirements.
Deep expertise in robotic surgical systems — from software architecture and safety validation to regulatory submission. We have worked on endoscopy, renal, prostate, ENT, and automated positioning systems.
Using advanced technologies and deep understanding of clinical users, our development team turns visions and goals into beautifully designed, clinically validated, manufacturable products.
Medical device cybersecurity and patient data privacy are regulatory requirements — not optional. QUASYS integrates security from the first design decision.
FDA pre-market and post-market cybersecurity guidance compliance, IEC 81001-5-1 for health software, and full threat modeling.
Comprehensive HIPAA compliance consulting and GDPR Privacy by Design implementation for medical devices handling patient data.
IoT medical device communication security, cloud-hosted SaMD architecture review, and electronic records compliance.
QUASYS builds a global regulatory strategy early — mapping timelines, dossier requirements, and parallel submission opportunities to minimize your time to market.
User acceptability and clinical validation are non-negotiable for approval. QUASYS builds the evidence systematically.
Clinical Evaluation Reports per MDR Annex XIV and MEDDEV 2.7.1 Rev.4. Equivalent device analysis, systematic literature review, and PMCF planning.
CSV protocols per 21 CFR Part 11 and EU Annex 11. Test case creation, execution, and validation summary reports. IQ/OQ/PQ documentation.
PMCF plan design, periodic safety update reports (PSUR), post-market surveillance reports, and vigilance system implementation.
IEC 62366-1 / HFE — Making your device safe through user understanding
Embedded into every phase of development — not added at the end. QUASYS builds robust quality and risk management systems that satisfy every major regulator.
From diagnostic imaging to surgical robotics — our clients span the full breadth of the medical device industry.
Choose the partnership structure that fits your stage, budget, and team. QUASYS adapts to you — not the other way around.
Monthly retainer for ongoing regulatory and quality guidance. Best for startups needing continuous expert support without full-time hires.
Defined scope, timeline and deliverables. Ideal for specific milestones: 510(k) submissions, V&V protocols, or clinical evaluations.
QUASYS acts as your regulatory and quality department. Full accountability, audit readiness, and continuous compliance monitoring.
End-to-end design and software development. Your dedicated QUASYS team handles all technical deliverables and design control outputs.
QUASYS Academy provides comprehensive training covering all critical topics in the medical device industry — from regulatory fundamentals to advanced software validation.
Talk to a QUASYS expert today. We'll map out your fastest, most defensible path from concept to approval.
Whether you're a first-time founder with a device idea or an established manufacturer entering a new market — QUASYS has the expertise to guide you.